Join Isabella Rios and Matty Slingsby for an in-depth review of the current oligonucleotide landscape for neurological disorders. This webinar will examine the latest developments across the preclinical and clinical pipeline, explore recent commercial activity, and highlight the therapies and trends expected to influence the future direction of the field. Attendees will gain a clearer understanding of where innovation is occurring, which programmes are generating momentum, and what to watch as the market continues to evolve.
Key Highlights:
- Comprehensive overview of the preclinical and clinical oligonucleotide pipeline for neurological disorders
- Analysis of recent commercial developments, partnerships, investments, and market activity
- Review of emerging programmes and therapies to watch across the neurology landscape
- Insights into key trends shaping future innovation and commercial opportunity
- Strategic outlook on the evolving role of oligonucleotides in treating neurological diseases
Why Attend?
- Stay informed on the latest advancements in oligonucleotide therapeutics for neurological disorders
- Benchmark the competitive landscape and identify key players driving innovation
- Understand how commercial activity is influencing investment and development strategies
- Discover emerging therapies and programmes that could shape the future of neurological treatment
- Gain expert perspectives on opportunities and challenges across this rapidly evolving market
Register now for an informative session.
Webinar Leaders
Isabella Rios
Researcher at Beacon
Matty Slingsby
Commercial Manager at Beacon
You May Also Be Interested In…
Learn More About RNA
- The Most Comprehensive Way to Search the RNA Drug Development Landscape: Unique search ontologies based on RNA drug and trial characteristics
- Market Leading Approach to RNA Preclinical & Clinical Data Curation: Manual curation of key RNA research and development data points by RNA research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search RNA company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
